| | Class 3 Device Recall Coagulation Factor VIII Deficient Plasma (OTXW) |  |
| Date Initiated by Firm | July 08, 2005 |
| Date Posted | August 16, 2005 |
| Recall Status1 |
Terminated 3 on August 10, 2006 |
| Recall Number | Z-1374-05 |
| Recall Event ID |
32691 |
| 510(K)Number | K924396 |
| Product Classification |
Plasma, Coagulation Factor Deficient - Product Code GJT
|
| Product | Coagulation Factor VIII Deficient Plasma (OTXW). Factor Deficiency Test |
| Code Information |
Lot numbers 503845A, 503846A, and 503847D |
Recalling Firm/ Manufacturer |
Dade Behring , Inc. 500 GBC Dr., Mailstop 514 PO BOX 6101 Newark DE 19714-6101
|
| For Additional Information Contact | Rebecca S. Ayash 302-631-6276 |
Manufacturer Reason for Recall | sample may exhibit falsely high results |
FDA Determined Cause 2 | Other |
| Action | On 7/13/05, the recalling firm issued letters to their customers informing them of the problem and the need to discontinue use and to discard any remaining product. |
| Quantity in Commerce | 3255 packs |
| Distribution | The product was shipped to medical facilities and laboratories in AR, AZ, CA, FL, GA, ID, IL, IN, KS, KY, MA, MD, NC, ND, NV, NY, OH, OK, PA, TX, VA, WA, WI, and WV. The products were also shipped to Germany, Belgium, Switzerland, Sweden, Netherlands, Russia, Spain, France, Italy, Portugal, Australia, Chile, China, Saudi Arabi, Taiwan, and Uraguay. |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
| 510(K) Database | 510(K)s with Product Code = GJT
|
|
|
|